miRoncol Health is pleased to announce the appointment of Victoria Xu as its new Chief Executive Officer, effective April 2024.
As miRoncol’s first committed investor and advisor, and with a Master’s in Bioinformatics and Public Management, Victoria Xu will lead miRoncol Health’s mission to provide healthy individuals a new line of defense against cancer through real-time, blood-based multi-cancer risk assessment using microRNA (miRNA) technology. Passionate about prevention and sustainability, she champions responsible innovation that improves quality of life and planetary health.
“There is no better way to contribute than leading an amazing team to make a breakthrough invention a reality to save real lives. I also feel extremely lucky that I can have my daily work combining all my education, career, and personal passion!” — Victoria Xu